Changes in mipomersen dosing regimen provide similar exposure with improved tolerability in randomized placebo-controlled study of healthy volunteers

Changes in mipomersen dosing regimen provide similar exposure with improved tolerability in randomized placebo-controlled study of healthy volunteers

Item
http://www.wikidata.org/entity/Q34297049
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisClinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro(®)): a second-generation antisense oligonucleotide inhibitor of apolipoprotein BThe role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations.Injection site reactions after subcutaneous oligonucleotide therapyStacking up CRISPR against RNAi for therapeutic gene inhibition.Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factorsSuppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.
P2860

Changes in mipomersen dosing regimen provide similar exposure with improved tolerability in randomized placebo-controlled study of healthy volunteers

Item
http://www.wikidata.org/entity/Q34297049
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@ast
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@en
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@nl
type
label
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@ast
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@en
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@nl
prefLabel
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@ast
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@en
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Changes in mipomersen dosing r ...... ed study of healthy volunteers
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932